[Benefits and risks of immunostimulation with interleukin 12]

Correction: Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation.

Mucosal immunology·2018

Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation.

Mucosal immunology·2018

A dietary flavone confers communicable protection against colitis through NLRP6 signaling independently of inflammasome activation.

Mucosal immunology·2017

Unravelling the roles of innate lymphoid cells in cerebral malaria pathogenesis.

Parasite immunology·2017

Neutrophilic NLRP3 inflammasome-dependent IL-1β secretion regulates the γδT17 cell response in respiratory bacterial infections.

Mucosal immunology·2017

The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation.

Mucosal immunology·2016

[Nicotine Harms the Heart: No Safe Product, No Excuse for Political Inaction].

Deutsche medizinische Wochenschrift (1946)·2026

[Mind the bat: Rare Infection as Lung Cancer Mimic - a Case Report].

Deutsche medizinische Wochenschrift (1946)·2026

[Multimorbidity and frailty as geriatric syndromes - Similarities and differences].

Deutsche medizinische Wochenschrift (1946)·2026

[Multimorbidity in Geriatric Oncology].

Deutsche medizinische Wochenschrift (1946)·2026

[Multimorbidity in neurodegenerative diseases].

Deutsche medizinische Wochenschrift (1946)·2026

[Chronic obstructive pulmonary disease (COPD), advanced age, and comorbidities].

Deutsche medizinische Wochenschrift (1946)·2026

TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

Cancer immunology research·2026

Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Practice Patterns in Inflammatory Bowel Disease in Pakistan: A National Survey of Physician Confidence and Therapeutic Strategies.

Inflammatory intestinal diseases·2026

Related Experiment Videos

[Benefits and risks of immunostimulation with interleukin 12]

Related Concept Videos

Correction: Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation.

Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation.

A dietary flavone confers communicable protection against colitis through NLRP6 signaling independently of inflammasome activation.

Unravelling the roles of innate lymphoid cells in cerebral malaria pathogenesis.

Neutrophilic NLRP3 inflammasome-dependent IL-1β secretion regulates the γδT17 cell response in respiratory bacterial infections.

The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation.

[Nicotine Harms the Heart: No Safe Product, No Excuse for Political Inaction].

[Mind the bat: Rare Infection as Lung Cancer Mimic - a Case Report].

[Multimorbidity and frailty as geriatric syndromes - Similarities and differences].

[Multimorbidity in Geriatric Oncology].

[Multimorbidity in neurodegenerative diseases].

[Chronic obstructive pulmonary disease (COPD), advanced age, and comorbidities].

TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.

Practice Patterns in Inflammatory Bowel Disease in Pakistan: A National Survey of Physician Confidence and Therapeutic Strategies.

Related Experiment Videos

[Benefits and risks of immunostimulation with interleukin 12]

Related Concept Videos

Related Articles